Literature DB >> 24581454

Disability in schizophrenia: contributing factors and validated assessments.

Philip D Harvey1.   

Abstract

Patients with schizophrenia experience impairments in multiple domains of everyday life, including the ability to maintain social relationships, sustain employment, and live independently. These impairments typically persist after patients achieve symptom remission. Assessment of patients' functioning requires multiple information sources (such as the patient, a relative, or a case worker) and performance-based measures. Functional milestones (for example, marriage or a job) are not highly related to each other and require separate assessments. Clinicians could enhance their practice by being familiar with assessment tools, such as the University of California, San Diego, Performance-Based Skills Assessment (UPSA) and the MATRICS Consensus Cognitive Battery, which are designed to evaluate real-life skills and cognitive abilities. Although often considered together, cognitive and negative symptoms appear to have differential effects on domains of functioning and likely require separate treatment interventions. With targeted therapies and frequent contact with supportive clinicians, there is increasing evidence that patients can improve in their functioning in crucial areas that impact their quality of life. © Copyright 2014 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2014        PMID: 24581454     DOI: 10.4088/JCP.13049su1c.03

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  15 in total

1.  Functional Capacity Assessed by the Map Task in Individuals at Clinical High-Risk for Psychosis.

Authors:  Danielle McLaughlin; Ricardo E Carrión; Andrea M Auther; Doreen M Olvet; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Robert K Heinssen; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Terry E Goldberg; Philip D Harvey; Barbara A Cornblatt
Journal:  Schizophr Bull       Date:  2016-04-22       Impact factor: 9.306

2.  The 20-Year Longitudinal Trajectories of Social Functioning in Individuals With Psychotic Disorders.

Authors:  Eva Velthorst; Anne-Kathrin J Fett; Avraham Reichenberg; Greg Perlman; Jim van Os; Evelyn J Bromet; Roman Kotov
Journal:  Am J Psychiatry       Date:  2016-12-16       Impact factor: 18.112

3.  The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia.

Authors:  Silvana Galderisi; Alessandro Rossi; Paola Rocca; Alessandro Bertolino; Armida Mucci; Paola Bucci; Paola Rucci; Dino Gibertoni; Eugenio Aguglia; Mario Amore; Antonello Bellomo; Massimo Biondi; Roberto Brugnoli; Liliana Dell'Osso; Diana De Ronchi; Gabriella Di Emidio; Massimo Di Giannantonio; Andrea Fagiolini; Carlo Marchesi; Palmiero Monteleone; Lucio Oldani; Federica Pinna; Rita Roncone; Emilio Sacchetti; Paolo Santonastaso; Alberto Siracusano; Antonio Vita; Patrizia Zeppegno; Mario Maj
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

4.  European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia.

Authors:  Antonio Vita; Wolfgang Gaebel; Armida Mucci; Gabriele Sachs; Andreas Erfurth; Stefano Barlati; Federico Zanca; Giulia Maria Giordano; Louise Birkedal Glenthøj; Merete Nordentoft; Silvana Galderisi
Journal:  Eur Psychiatry       Date:  2022-09-05       Impact factor: 7.156

5.  The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis.

Authors:  Ricardo E Carrión; Andrea M Auther; Danielle McLaughlin; Ruth Olsen; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Barbara A Cornblatt
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 9.306

Review 6.  Efficacy and safety of aripiprazole for the treatment of schizophrenia: an overview of systematic reviews.

Authors:  Esther Letícia Amorim Ribeiro; Tácio de Mendonça Lima; Marcio Eduardo Bergamini Vieira; Sílvia Storpirtis; Patricia Melo Aguiar
Journal:  Eur J Clin Pharmacol       Date:  2018-06-15       Impact factor: 2.953

7.  Course of longitudinal psychosocial functioning in bipolar youth transitioning to adults.

Authors:  Erica J Lee; Heather Hower; Richard N Jones; Boris Birmaher; Michael Strober; Benjamin I Goldstein; John Merranko; Martin B Keller; Tina R Goldstein; Lauren M Weinstock; Daniel P Dickstein; Jeffrey I Hunt; Rasim S Diler; Neal D Ryan; Mary Kay Gill; David Axelson; Shirley Yen
Journal:  J Affect Disord       Date:  2020-03-05       Impact factor: 4.839

8.  Construct Validity of the Chinese Version of the Activities of Daily Living Rating Scale III in Patients with Schizophrenia.

Authors:  En-Chi Chiu; Yen Lee; Kuan-Yu Lai; Chian-Jue Kuo; Shu-Chun Lee; Ching-Lin Hsieh
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

9.  Cortical substrates and functional correlates of auditory deviance processing deficits in schizophrenia.

Authors:  Anthony J Rissling; Makoto Miyakoshi; Catherine A Sugar; David L Braff; Scott Makeig; Gregory A Light
Journal:  Neuroimage Clin       Date:  2014-10-01       Impact factor: 4.881

Review 10.  Early interventions in risk groups for schizophrenia: what are we waiting for?

Authors:  Iris E Sommer; Carrie E Bearden; Edwin van Dellen; Elemi J Breetvelt; Sasja N Duijff; Kim Maijer; Therese van Amelsvoort; Lieuwe de Haan; Raquel E Gur; Celso Arango; Covadonga M Díaz-Caneja; Christiaan H Vinkers; Jacob As Vorstman
Journal:  NPJ Schizophr       Date:  2016-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.